Concepedia

Nigel S. Cook

NS

36

Publications

1.6K

Citations

20

H-Index

1983

Active since

Affiliations

Novartis (Switzerland)(Current)

Psychiatry Baselland

Novartis (India)

The University of Sydney

Sanden (Japan)

Nigel S. Cook is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

1983–2022

36

Publications

36

In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.

Ulrich Quast, Nigel S. Cook · Journal of Pharmacology and Experimental Therapeutics · 1989 · 199 citations

Effects of apamin, quinine and neuromuscular blockers on calcium‐activated potassium channels in guinea‐pig hepatocytes.

Nigel S. Cook, D.G. Haylett · The Journal of Physiology · 1985 · 180 citations · Full text

Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915

Nigel S. Cook, Ulrich Quast, Robert P. Hof et al. · Journal of Cardiovascular Pharmacology · 1988 · 102 citations

Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers.

Robert P. Hof, Ulrich Quast, Nigel S. Cook et al. · Circulation Research · 1988 · 90 citations

, , +21

Anti‐vasoconstrictor effects of the K<sup>+</sup> channel opener cromakalim on the rabbit aorta—comparison with the calcium antagonist isradipine

Nigel S. Cook, Sheila W. Weir, M Danzeisen · British Journal of Pharmacology · 1988 · 85 citations · Full text

Rows per page

1–5 of 36